Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
Accuracy of drug categorizations for Medicaid rebates
| Accuracy of drug categorizations for Medicaid rebates |
| Pubbl/distr/stampa | [Washington, D.C.] : , : Department of Health and Human Services, Office of Inspector General, , 2009 |
| Descrizione fisica | 1 online resource (iv, 21 pages) : illustrations |
| Soggetto topico |
Medicare beneficiaries
Health insurance claims - United States Drugs - United States Rebates - United States Pharmaceutical policy - United States |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Altri titoli varianti | Accuracy of drug categorizations for Medicaid rebates |
| Record Nr. | UNINA-9910707236903321 |
| [Washington, D.C.] : , : Department of Health and Human Services, Office of Inspector General, , 2009 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
An Act to Amend the Federal Food, Drug, and Cosmetic Act with Respect to the Scope of New Chemical Exclusivity
| An Act to Amend the Federal Food, Drug, and Cosmetic Act with Respect to the Scope of New Chemical Exclusivity |
| Pubbl/distr/stampa | [Washington, D.C.] : , : [U.S. Government Publishing Office], , [2021] |
| Descrizione fisica | 1 online resource (4 unnumbered pages) |
| Soggetto topico |
Drug approval - United States
Pharmaceutical policy - United States Drug approval Pharmaceutical policy |
| Soggetto genere / forma | Statutes and codes. |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910716073503321 |
| [Washington, D.C.] : , : [U.S. Government Publishing Office], , [2021] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Addition of qualified drugs to the Medicaid federal upper limit list
| Addition of qualified drugs to the Medicaid federal upper limit list |
| Pubbl/distr/stampa | [Washington, D.C.] : , : Department of Health and Human Services, Office of Inspector General, , 2004 |
| Descrizione fisica | 1 online resource (iv, 22 pages) : illustrations |
| Soggetto topico |
Drugs - Prices - United States
Pharmaceutical services insurance - United States Pharmaceutical policy - United States |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Altri titoli varianti | Addition of qualified drugs to the Medicaid federal upper limit list |
| Record Nr. | UNINA-9910707235003321 |
| [Washington, D.C.] : , : Department of Health and Human Services, Office of Inspector General, , 2004 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
The adequacy of FDA to assure the safety of the nation's drug supply : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Tenth Congress, first session, February 13, March 22, 2007
| The adequacy of FDA to assure the safety of the nation's drug supply : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Tenth Congress, first session, February 13, March 22, 2007 |
| Descrizione fisica | 1 online resource (iv, 317 p.) : ill |
| Soggetto topico |
Drugs - United States - Testing
Pharmaceutical policy - United States |
| Soggetto non controllato |
United States
Drugs Pharmaceutical policy Political science Medical |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Altri titoli varianti | Adequacy of FDA to Assure the Safety of the Nation's Drug Supply |
| Record Nr. | UNINA-9910694379003321 |
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
|
Advancing the discipline of regulatory science for medical product development : an update on progress and a forward-looking agenda : workshop summary : proceedings of a workshop / / Morgan L. Boname, Amanda Wagner Gee, and Anne B. Claiborne, rapporteurs ; Forum on Drug Discovery, Development, and Translation [and three others]
| Advancing the discipline of regulatory science for medical product development : an update on progress and a forward-looking agenda : workshop summary : proceedings of a workshop / / Morgan L. Boname, Amanda Wagner Gee, and Anne B. Claiborne, rapporteurs ; Forum on Drug Discovery, Development, and Translation [and three others] |
| Autore | Boname Morgan L. |
| Pubbl/distr/stampa | Washington, District of Columbia : , : The National Academies Press, , 2016 |
| Descrizione fisica | 1 online resource (105 pages) : illustrations |
| Disciplina | 362.17820973 |
| Soggetto topico |
Pharmaceutical policy - United States
Drug development - Technological innovations - United States |
| ISBN |
0-309-43887-X
0-309-43885-3 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Introduction -- Characterizing the Implementation science landscape -- Regulatory science applications: using case studies to focus on approaches to advance the discipline -- Regulatory science infrastructure and workforce -- Challenges and opportunities in regulatory science -- Appendix A: Bibliography -- Appendix B: Workshop agenda -- Appendix C: Participant biographies. |
| Record Nr. | UNINA-9910798442303321 |
Boname Morgan L.
|
||
| Washington, District of Columbia : , : The National Academies Press, , 2016 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Advancing the discipline of regulatory science for medical product development : an update on progress and a forward-looking agenda : workshop summary : proceedings of a workshop / / Morgan L. Boname, Amanda Wagner Gee, and Anne B. Claiborne, rapporteurs ; Forum on Drug Discovery, Development, and Translation [and three others]
| Advancing the discipline of regulatory science for medical product development : an update on progress and a forward-looking agenda : workshop summary : proceedings of a workshop / / Morgan L. Boname, Amanda Wagner Gee, and Anne B. Claiborne, rapporteurs ; Forum on Drug Discovery, Development, and Translation [and three others] |
| Autore | Boname Morgan L. |
| Pubbl/distr/stampa | Washington, District of Columbia : , : The National Academies Press, , 2016 |
| Descrizione fisica | 1 online resource (105 pages) : illustrations |
| Disciplina | 362.17820973 |
| Soggetto topico |
Pharmaceutical policy - United States
Drug development - Technological innovations - United States |
| ISBN |
0-309-43887-X
0-309-43885-3 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Introduction -- Characterizing the Implementation science landscape -- Regulatory science applications: using case studies to focus on approaches to advance the discipline -- Regulatory science infrastructure and workforce -- Challenges and opportunities in regulatory science -- Appendix A: Bibliography -- Appendix B: Workshop agenda -- Appendix C: Participant biographies. |
| Record Nr. | UNINA-9910817967503321 |
|
Boname Morgan L.
|
||
| Washington, District of Columbia : , : The National Academies Press, , 2016 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Advancing the discipline of regulatory science for medical product development : an update on progress and a forward-looking agenda : workshop summary : proceedings of a workshop / / Morgan L. Boname, Amanda Wagner Gee, and Anne B. Claiborne, rapporteurs ; Forum on Drug Discovery, Development, and Translation [and three others]
| Advancing the discipline of regulatory science for medical product development : an update on progress and a forward-looking agenda : workshop summary : proceedings of a workshop / / Morgan L. Boname, Amanda Wagner Gee, and Anne B. Claiborne, rapporteurs ; Forum on Drug Discovery, Development, and Translation [and three others] |
| Pubbl/distr/stampa | Washington, District of Columbia : , : The National Academies Press, , 2016 |
| Descrizione fisica | 1 online resource (105 pages) : illustrations |
| Disciplina | 362.17820973 |
| Soggetto topico |
Pharmaceutical policy - United States
Drug development - Technological innovations - United States |
| Soggetto genere / forma | Electronic books. |
| ISBN | 0-309-43885-3 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910478862603321 |
| Washington, District of Columbia : , : The National Academies Press, , 2016 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Audits of Medicare prescription drug plan sponsors
| Audits of Medicare prescription drug plan sponsors |
| Pubbl/distr/stampa | [Washington, D.C.] : , : Department of Health and Human Services, Office of Inspector General, , 2011 |
| Descrizione fisica | 1 online resource (iii, 26 pages) : illustrations |
| Soggetto topico |
Medicare - Auditing
Pharmaceutical services insurance - United States - Auditing Pharmaceutical policy - United States |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Altri titoli varianti | Audits of Medicare prescription drug plan sponsors |
| Record Nr. | UNINA-9910707250603321 |
| [Washington, D.C.] : , : Department of Health and Human Services, Office of Inspector General, , 2011 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Beneficiary utilization of albuterol and levalbuterol under Medicare Part B
| Beneficiary utilization of albuterol and levalbuterol under Medicare Part B |
| Pubbl/distr/stampa | [Washington, D.C.] : , : Department of Health and Human Services, Office of Inspector General, , 2009 |
| Descrizione fisica | 1 online resource (iv, 28 pages) : illustrations |
| Soggetto topico |
Medicare beneficiaries
Health insurance claims - United States Albuterol Asthma - Treatment - United States - Auditing Pharmaceutical policy - United States |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Altri titoli varianti | Beneficiary utilization of albuterol and levalbuterol under Medicare Part B |
| Record Nr. | UNINA-9910707237103321 |
| [Washington, D.C.] : , : Department of Health and Human Services, Office of Inspector General, , 2009 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Beyond health insurance [[electronic resource] ] : public policy to improve health / / edited by Lorens Helmchen, Robert Kaestner, Anthony Lo Sasso
| Beyond health insurance [[electronic resource] ] : public policy to improve health / / edited by Lorens Helmchen, Robert Kaestner, Anthony Lo Sasso |
| Pubbl/distr/stampa | Bingley, : JAI Press, 2008 |
| Descrizione fisica | 1 online resource (219 p.) |
| Disciplina |
362.10973
362.11 |
| Altri autori (Persone) |
HelmchenLorens
KaestnerRobert Lo SassoAnthony T (Anthony Thomas) |
| Collana | Advances in health economics and health services research |
| Soggetto topico |
Medical policy - United States
Health promotion - Government policy - United States Medical informatics - United States Pharmaceutical policy - United States |
| Soggetto genere / forma | Electronic books. |
| ISBN |
1-280-77105-4
9786613681829 1-84855-181-9 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Beyond Health Insurance: Public Policy to Improve Health; Copyright page; Contents; List of contributors; Introduction; Reducing racial and ethnic disparities in health; Preventing disease and promoting health; Developing and regulating pharmaceuticals; Consumer information; Summary; Reference; Chapter 1. Quantifying national spending on wellness and prevention; Background; Methods; Results; Discussion; Notes; Acknowledgments; References; Chapter 2. Achieving the healthy people 2010 goal of elimination of health disparities: what will it takequest; Introduction
Progress in eliminating health disparitiesLimits of current strategy; Selecting policies; Early child intervention; Enhanced primary care within health centers; Conclusion; References; Chapter 3. Influence, information overload, and information technology in health care; 1. Introduction; 2. The diffusion of innovations in medicine; 3. Empirical evidence on the influence of computer-generated messages; 4. Influence and physician learning: a simple analytical framework; 5. Conclusion; Notes; References; Chapter 4. Health disparities and direct-to-consumer advertising of pharmaceutical products 1. Introduction2. Background on health disparities, use of pharmaceuticals, and DTC advertising; 3. Data on consumer exposure to television DTC advertisements; 4. Consumer exposure to DTC advertisements; 5. Conclusions; Notes; Acknowledgments; References; Chapter 5. Pharmaceutical innovation and the longevity of Australians: a first look; 1. Embodied technological progress hypothesis; 2. Econometric model; 3. Data sources and descriptive statistics; 4. Empirical results; 5. Summary and discussion; Notes; References; Chapter 6. Spillover effects of prescription drug withdrawals; Introduction Conceptual frameworkMethods; Data and empirical specification; Empirical results; Predicting negative spillovers or competitive benefits; Generalizability; Conclusions; Notes; Acknowledgments; References; Chapter 7. The psychology of nutrition messages; Introduction; Consumer cognition; The history of nutrition messages in the United States; Firm incentives to hijack; Research design and methods; Results; Further research; Policy implications; Conclusion; Notes; References; Chapter 8. Evaluation criteria for report cards of healthcare providers; Introduction Potential benefits of report cardsPotential risks of report cards; Evaluation criteria for report cards; The bottom line: report cards - are the benefits worth the risksquest; References; Chapter 9. Evaluating the Value of Genomic Diagnostics: Implications for Clinical Practice and Public Policy; The advent of genomic diagnostics; Measuring value: the economic approach; Measuring value: the epidemiologic approach; Measuring value and the importance of clinical utility; A comprehensive framework of evaluating the value of genomic diagnostics Some policy implications: an illustrative case study |
| Record Nr. | UNINA-9910455032603321 |
| Bingley, : JAI Press, 2008 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
